- Home
- HIVE vs BME Comparison
HIVE vs BME Comparison
Compare HIVE & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Company Overview
Basic Information| Metric | HIVE | BME |
|---|---|---|
| Founded | 1987 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Trusts Except Educational Religious and Charitable |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 511.6M | 547.5M |
| IPO Year | 2017 | 2005 |
Fundamental Metrics
Financial Performance| Metric | HIVE | BME |
|---|---|---|
| Price | $2.04 | $38.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $6.75 | N/A |
| AVG Volume (30 Days) | ★ 8.2M | 33.7K |
| Earning Date | 02-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $169.51 | N/A |
| Revenue Next Year | $39.45 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.26 | $34.18 |
| 52 Week High | $7.84 | $42.74 |
Technical Indicators
Market Signals| Indicator | HIVE | BME |
|---|---|---|
| Relative Strength Index (RSI) | 41.62 | 29.19 |
| Support Level | $1.98 | $35.48 |
| Resistance Level | $2.33 | $42.55 |
| Average True Range (ATR) | 0.12 | 0.55 |
| MACD | 0.01 | -0.19 |
| Stochastic Oscillator | 25.68 | 12.39 |
Price Performance
Historical Comparison HIVE
BME
About HIVE HIVE Digital Technologies Ltd.
HIVE Digital Technologies Ltd is in the business of providing infrastructure solutions in the blockchain industry. It focuses on the mining and sale of digital currencies. Its geographical segments include Canada, Sweden, Iceland, Switzerland, and Bermuda, out of which the majority of the revenue comes from Bermuda.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.